State Owned Pharmaceutical Company Increases Capital to Approximately 780 Million, a 40% Increase

Tianyancha App shows that recently, Guobang Pharmaceutical has undergone a business change, with its registered capital increasing from approximately 560 million RMB to approximately 780 million RMB, an increase of 40%. The company was established in March 1996, with Qiu Jiajun as the legal representative. Its business scope includes drug production, drug wholesale, drug import and export, animal medicine production, and animal medicine operation, with shares held by Xinchang Ande Trading Co., Ltd., Xinchang Qingyu Investment Development Co., Ltd., Qiu Jiajun, and others.